Manganese enhanced magnetic resonance imaging of normal and ischemic canine heart

Magnetic Resonance in Medicine

Volumn 54, Issue 1, 2005, Pages 196-200

  Hu, Tom C C ^a,c   Christian, Timothy F ^b,d   Aletras, Anthony H ^b   Taylor, Joni L ^b   Koretsky, Alan P ^a   Ara, Andrew E ^a,e  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^c GLAXOSMITHKLINE   (United States)

^d UNIVERSITY OF WISCONSIN MADISON   (United States)

^e National Institutes of Health   (United States)

Author keywords

Manganese; Myocardial ischemia; Myocardial perfusion; Myocardial viability; Safety

Indexed keywords

ACCIDENT PREVENTION; CHLORINE COMPOUNDS; HEART; MAGNETIC RESONANCE IMAGING; MANGANESE;

CONTRAST ENHANCEMENT; DOSE-RESPONSE CURVES; LEFT ANTERIOR DESCENDING; MANGANESE-ENHANCED MAGNETIC RESONANCE IMAGING; MYOCARDIAL ISCHEMIA; MYOCARDIAL PERFUSION; MYOCARDIAL VIABILITY; SIGNAL INTENSITIES;

MANGANESE COMPOUNDS;

MANGANESE CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; HEART INFARCTION; HEART MUSCLE ISCHEMIA; IMAGE ANALYSIS; LEFT ANTERIOR DESCENDING CORONARY ARTERY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING;

EID: 21244492784     PISSN: 07403194     EISSN: None     Source Type: Journal    
DOI: 10.1002/mrm.20516     Document Type: Article

References (22)

1. Pogwizd SM, Schlotthauer K, Li L, Yuan W, Bers DM. Arrhythmogenesis and contractile dysfunction in heart failure: Roles of sodium-calcium exchange, inward rectifier potassium current, and residual beta-adrenergic responsiveness. Circ Res 2001;88:1159-1167.
2. Saeed M. New concepts in characterization of ischemically injured myocardium by MRI. Exp Biol Med (Maywood) 2001;226:367-376.
3. Mendonca-Dias MH, Gaggelli E, Lauterbur PC. Paramagnetic contrast agents in nuclear magnetic resonance medical imaging. Seminin Nucl Med 1983;13:364-376.
4. Hu TC, Pautler RG, MacGowan GA, Koretsky AP. Manganese-enhanced MRI of mouse heart during changes in inotropy. Magn Reson Med 2001;46:884-890.
5. Pautler RG, Silva AC, Koretsky AP. In vivo neuronal tract tracing using manganese-enhanced magnetic resonance imaging. Magn Reson Med 1998;40:740-748.
6. Brurok H, Skoglund T, Berg K, Skarra S, Karlsson JO, Jynge P. Myocardial manganese elevation and proton relaxivity enhancement with manganese dipyridoxyl diphosphate. Ex vivo assessments in normally perfused and ischemic guinea pig hearts. NMR Biomed 1999;12:364-372.
7. Lin YJ, Koretsky AP. Manganese ion enhances T1-weighted MRI during brain activation: an approach to direct imaging of brain function. Magn Reson Med 1997;38:378-388.
8. Saeed M, Higgins CB, Geschwind JF, Wendland MF. T1-relaxation kinetics of extracellular, intracellular and intravascular MR contrast agents in normal and acutely reperfused infarcted myocardium using echo-planar MR imaging. Eur Radiol 2000;10:310-318.
9. Brady TJ, Goldman MR, Pykett IL, Buonanno FS, Kistler JP, Newhouse JH, Burt CT, Hinshaw WS, Pohost GM. Proton nuclear magnetic resonance imaging of regionally ischemic canine hearts: effect of paramagnetic proton signal enhancement. Radiology 1982;144:343-347.
10. Chauncey DM, Jr., Schelbert HR, Halpern SE, Delano F, McKegney ML, Ashburn WL, Hagan PL. Tissue distribution studies with radioactive manganese: a potential agent for myocardial imaging. J Nucl Med 1977;18:933-936.
11. Atkins HL, Som P, Fairchild RG, Hui J, Schachner E, Goldman A, Ku T. Myocardial positron tomography with manganese-52m. Radiology 1979;133:769-774.
12. Pal PK, Samii A, Calne DB. Manganese neurotoxicity: a review of clinical features, imaging and pathology. Neurotoxicology 1999;20:227-238.
13. Ni Y, Petre C, Bosmans H, Miao Y, Grant D, Baert AL, Marchal G. Comparison of manganese biodistribution and MR contrast enhancement in rats after intravenous injection of MnDPDP and MnCl2. Acta Radiol 1997;38:700-707.
14. Brurok H, Schjott J, Berg K, Karlsson JO, Jynge P. Effects of MnDPDP, DPDP-, and MnCl2 on cardiac energy metabolism and manganese accumulation. An experimental study in the isolated perfused rat heart Invest Radiol 1997;32:205-211.
15. Storey P, Danias PG, Post M, Li W, Seoane PR, Harnish PP, Edelman RR, Prasad PV. Preliminary evaluation of EVP 1001-1: a new cardiac-specific magnetic resonance contrast agent with kinetics suitable for steady-state imaging of the ischemic heart. Invest Radiol 2003;38:642-652.
16. Narita K, Kawasaki F, Kita H. Mn and Mg influxes through Ca channels of motor nerve terminals are prevented by verapamil in frogs. Brain Res 1990;510:289-295.
17. Langer GA. Calcium and the heart. New York: Raven Press; 1990. p199-268.
18. Brurok H, Schjott J, Berg K, Karlsson JO, Jynge P, Schojtt J. Effects of manganese dipyridoxyl diphosphate, dipyridoxyl diphosphate-, and manganese chloride on cardiac function. An experimental study in the Langendorff perfused rat heart. Invest Radiol 1995;30:159-167.
19. Kim RJ, Fieno DS, Parrish TB, Harris K, Chen EL, Simonetti O, Bundy J, Finn JP, Klocke FJ, Judd RM. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 1999;100:1992-2002.
20. Federle MP, Chezmar JL, Rubin DL, Weinreb JC, Freeny PC, Seminelka RC, Brown JJ, Borello JA, Lee JK, Mattrey R, Dachman AH, Saini S, Harmon B, Fenstermacher M, Pelsang RE, Harms SE, Mitchell DG, Halford HH, Anderson MW, Johnson CD, Francis IR, Bova JG, Kenney PJ, Klippenstein DL, Foster GS, Turner DA. Safety and efficacy of mangafodipir trisodium (MnDPDP) injection for hepatic MRI in adults: results of the U.S. multicenter phase III clinical trials (safety). J Magn Reson Imaging 2000;12:186-197.
21. Skjold A, Vangberg T, Kristoffersen A, Haraldseth O, Larsson HW, Jynge P. Preliminary experience with intracellular manganese ions as contrast agents in the human myocardium. In: Proceedings of the 12th Annual Meeting of ISMRM, Kyoto, Japan, 2004. Vol 11, p 1722.
22. Jynge P, Brurok H, Asplund A, Towart R, Refsum H, Karlsson JO. Cardiovascular safety of MnDPDP and MnCl2. Acta Radiol 1997;38:740-749.